Related references
Note: Only part of the references are listed.Involvement of Nrf2-GSH signaling in TGFβ1-stimulated epithelial-to-mesenchymal transition changes in rat renal tubular cells
In-geun Ryoo et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
SETting OP449 into the PP2A-Activating Drug Family
Paolo Neviani et al.
CLINICAL CANCER RESEARCH (2014)
Anticancer cardamonin analogs suppress the activation of NF-kappaB pathway in lung cancer cells
Weiyan He et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
mTOR inhibition of cardamonin on antiproliferation of A549 cells is involved in a FKBP12 independent fashion
Ying Tang et al.
LIFE SCIENCES (2014)
Novel anti-nociceptive effects of cardamonin via blocking expression of cyclooxygenase-2 and transglutaminase-2
Mi Kyung Park et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
LPS promotes epithelial-mesenchymal transition and activation of TLR4/JNK signaling
Hangyu Li et al.
TUMOR BIOLOGY (2014)
Cardamonin Suppresses the Proliferation of Colon Cancer Cells by Promoting β-Catenin Degradation
Seoyoung Park et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2013)
Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy
Yhun Yhong Sheen et al.
BIOMOLECULES & THERAPEUTICS (2013)
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis
Sahar A. Saddoughi et al.
EMBO MOLECULAR MEDICINE (2013)
Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation
Mi Kyung Park et al.
EUROPEAN JOURNAL OF CANCER (2013)
Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32
Hye Ja Lee et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
Novel suppressive effects of cardamonin on the activity and expression of transglutaminase-2 lead to blocking the migration and invasion of cancer cells
Mi Kyung Park et al.
LIFE SCIENCES (2013)
Suppression of Transglutaminase-2 is Involved in Anti-Inflammatory Actions of Glucosamine in 12-O-Tetradecanoylphorbol-13-Acetate-Induced Skin Inflammation
Mi Kyung Park et al.
BIOMOLECULES & THERAPEUTICS (2012)
Cardamonin sensitizes tumour cells to TRAIL through ROS- and CHOP-mediated up-regulation of death receptors and down-regulation of survival proteins
Vivek R. Yadav et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Cardamonin from Alpinia rafflesiana inhibits inflammatory responses in IFN-γ/LPS-stimulated BV2 microglia via NF-κB signalling pathway
Yuh-Lit Chow et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2012)
TGF-β-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells
Mikiko Kawata et al.
JOURNAL OF BIOCHEMISTRY (2012)
c-Jun N-Terminal Kinase 1 Promotes Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition via Control of Linker Phosphorylation and Transcriptional Activity of Smad3
Jos L. J. van der Velden et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Alpha4 Is a Ubiquitin-Binding Protein That Regulates Protein Serine/Threonine Phosphatase 2A Ubiquitination
Jamie L. McConnell et al.
BIOCHEMISTRY (2010)
Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer
Tony Blick et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
Epithelial to mesenchymal transition: The doorway to metastasis in human lung cancers
Chadrick E. Denlinger et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2010)
Sustained c-Jun-NH2-Kinase Activity Promotes Epithelial-Mesenchymal Transition, Invasion, and Survival of Breast Cancer Cells by Regulating Extracellular Signal-Regulated Kinase Activation
Jinhua Wang et al.
MOLECULAR CANCER RESEARCH (2010)
TGFβ signalling: a complex web in cancer progression
Hiroaki Ikushima et al.
NATURE REVIEWS CANCER (2010)
α-Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis
Po-Hsien Huang et al.
CARCINOGENESIS (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung
Ludmila Prudkin et al.
MODERN PATHOLOGY (2009)
Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity
C. H. Switzer et al.
ONCOGENE (2009)
Prognostic significance of hypoxia-inducible factor-1α, TWIST1 and Snail expression in resectable non-small cell lung cancer
J-J Hung et al.
THORAX (2009)
Jun N-terminal kinase 1 regulates epithelial-to-mesenchymal transition induced by TGF-β1
John F. Alcorn et al.
JOURNAL OF CELL SCIENCE (2008)
TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-β
Motozo Yamashita et al.
MOLECULAR CELL (2008)
Transtorming growth factor β1 induces epithelial-to-mesenchymcl transition of A549 cells
Ju Hee Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
Snail, ZEB and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
Hector Peinado et al.
NATURE REVIEWS CANCER (2007)
Separation and determination of alpinetin and cardamonin by reverse micelle electrokinetic capillary chromatography
Shumin Wang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)
Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-κB inactivation
Dae-Seok Kim et al.
CANCER RESEARCH (2006)
Cardamonin, inhibits pro-inflammatory mediators in activated RAW 264.7 cells and whole blood
Syahida Ahmad et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients
BA Williams et al.
ANNALS OF THORACIC SURGERY (2006)
Global cancer statistics, 2002
DM Parkin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2005)
Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice
S Kins et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
A novel and essential mechanism determining specificity and activity of protein phosphatase 2A (PP2A) in vivo
T Fellner et al.
GENES & DEVELOPMENT (2003)
Signal transduction by the JNK group of MAP kinases
RJ Davis
CELL (2000)
Share Paper
